Cannabinoid Hyperemesis Syndrome: A Rising Complication
Saar Peles,
No information about this author
Roy Khalifé,
No information about this author
Anthony M. Magliocco
No information about this author
et al.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 13, 2025
Cannabis,
commonly
known
as
marijuana,
is
a
psychoactive
plant
that
has
been
used
for
both
medicinal
and
recreational
purposes
centuries.
It
contains
over
100
biologically
active
compounds
cannabinoids,
the
most
notable
of
which
are
tetrahydrocannabinol
(THC)
cannabidiol
(CBD).
THC
responsible
euphoric
hallucinogenic
effects
associated
with
cannabis
use,
while
CBD
often
utilized
its
potential
therapeutic
benefits,
such
pain
relief
anti-inflammatory
properties.
Despite
widespread
reputation
alleviating
nausea
stimulating
appetite,
chronic
use
linked
to
paradoxical
condition
cannabinoid
hyperemesis
syndrome
(CHS).
CHS
disorder
paradoxically
causes
abdominal
pain,
nausea,
uncontrollable
vomiting
in
long-term
users
rather
than
reducing
nausea.
Misdiagnosis
this
extremely
common,
it
confused
cyclic
(CVS).
The
underlying
pathogenesis
not
completely
understood,
though
several
mechanisms
have
proposed.
Although
considered
rare,
there
steady
increase
diagnoses
Emergency
Department
(ED).
This
article
summarizes
symptoms,
pathogenesis,
treatments
CHS,
differential
further
our
understanding
condition.
Language: Английский
A retrospective medical record audit of the management of cannabis‐related emergency department presentations, hospital admissions and hyperemesis of pregnant women who self‐reported non‐medicinal cannabis use to a substance use in parenting and pregnancy service
Drug and Alcohol Review,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 10, 2025
Abstract
Introduction
Research
on
cannabis‐related
hyperemesis
and
its
identification
management
during
pregnancy
is
scarce.
This
study
aimed
to
investigate
the
of
emergency
department
(ED)
presentations,
hospital
admissions
pregnant
women
who
self‐reported
non‐medicinal
cannabis
use
a
substance
in
parenting
service
(SUPPS).
Methods
A
retrospective
medical
record
audit
was
conducted
75
SUPPS
patients
identified
as
their
primary
drug
concern
gave
birth
between
January
2015
May
2020
Australia.
Their
ED
presentations
12
months
prior
baby's
delivery
were
examined.
descriptive
analysis
conducted.
Results
The
had
232
183
admissions.
History
documented
34%
53%
Screening
current
45%
Withdrawal
symptoms
3%
13%
Cannabis
status
asked
36%
52%
Take
home
medications
provided
12%
Referral
made
7%
admissions,
but
none
from
ED.
Discussion
Conclusions
Gaps
identified.
Routine
screening
should
be
enable
early
pregnancy.
Language: Английский
Cannabis Hyperemesis Syndrome in Youth: Clinical Insights and Public Health Implications
International Journal of Environmental Research and Public Health,
Journal Year:
2025,
Volume and Issue:
22(4), P. 633 - 633
Published: April 17, 2025
This
review
focuses
on
Cannabis
Hyperemesis
Syndrome
(CHS)
in
youth,
a
condition
linked
to
chronic
cannabis
use
and
characterized
by
cyclic
vomiting,
abdominal
pain,
dehydration.
The
objectives
were
explore
CHS
progression
youth
its
impact
health,
assess
current
treatment
strategies.
There
are
the
three
distinct
phases
of
CHS:
prodromal,
hyperemetic,
recovery.
During
prodromal
phase,
individuals
experience
early
morning
nausea
discomfort,
often
mistakenly
alleviated
continued
use.
hyperemetic
phase
is
marked
severe
dehydration,
complications
like
electrolyte
imbalances,
leading
potentially
serious
health
risks.
Temporary
relief
may
be
experienced
through
hot
showers
or
baths.
In
recovery
symptoms
gradually
resolve,
normal
eating
bathing
habits
return.
emphasizes
physical
psychological
impacts
highlighting
potential
for
misdiagnosis
importance
intervention.
It
stresses
need
targeted
educational
efforts
schools,
healthcare
settings,
public
campaigns
prevent
delayed
diagnosis
improve
outcomes.
Findings
underscore
increasing
provider
awareness
promoting
preventive
education.
also
advocates
further
research
into
pathophysiology
diagnostic
protocols
young
populations.
Language: Английский
None
Anya Ramsamooj,
No information about this author
Joy Aa,
No information about this author
Ibrahim Bs
No information about this author
et al.
American Journal of Biomedical Science & Research,
Journal Year:
2023,
Volume and Issue:
20(3)
Published: Oct. 26, 2023
Cannabinoids
are
known
to
have
clinical
significance
in
relieving
GI
symptoms,
such
as
nausea
and
vomiting.However,
the
increasing
incidence
of
Cannabinoid
Hyperemesis
Syndrome
(CHS),
where
patients
episodes
cyclic
vomiting
abdominal
pain,
seems
contradict
their
intended
medicinal
use.This
case
report
details
observation
CHS
a
young
woman
with
six-month
history
distress,
without
any
associated
conditions.She
visited
multiple
emergency
departments
before
this
visit
no
resolution
her
condition.Although
she
initially
denied
drug
use,
most
recent
department
revealed
positive
urine
screen
for
THC.CHS
is
rare
condition
an
uncommon
diagnosis,
which
made
particularly
difficult
diagnose
at
first
glance.While
hot
showers
baths,
topical
capsaicin,
other
antiemetic
medications
can
help
alleviate
symptoms
CHS,
there
established
treatment
regimen.Thus,
effective
method
resolving
cessation
THC
promote
awareness
among
medical
professionals
users
so
that
be
recognized
resolved
future
cases.Furthermore,
it
provides
call
focus
research
on
discovering
primary
therapeutics
factors
make
some
more
susceptible
than
others.
Language: Английский